Literature DB >> 17191386

Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer.

George Coukos1, Jose R Conejo-Garcia, Ron Buckanovich, Fabian Benencia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17191386     DOI： 10.1007/978-0-387-34814-8_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  12 in total

1.  Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Authors:  Junko Matsuzaki; Sacha Gnjatic; Paulette Mhawech-Fauceglia; Amy Beck; Austin Miller; Takemasa Tsuji; Cheryl Eppolito; Feng Qian; Shashikant Lele; Protul Shrikant; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 2.  Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes.

Authors:  Juan R Cubillos-Ruiz; Melanie Rutkowski; Jose R Conejo-Garcia
Journal:  Cell Cycle       Date:  2010-01-26       Impact factor: 4.534

3.  MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma.

Authors:  Jing Lu; Jimin Zhao; Kangdong Liu; Jun Zhao; Hongyan Yang; Youtian Huang; Zhenzhu Qin; Ruihua Bai; Pei Li; Junfen Ma; Wenhai Yan; Mingyao Zhao; Ziming Dong
Journal:  Cell Mol Life Sci       Date:  2010-03-10       Impact factor: 9.261

4.  In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.

Authors:  Uciane K Scarlett; Juan R Cubillos-Ruiz; Yolanda C Nesbeth; Diana G Martinez; Xavier Engle; Andrew T Gewirtz; Cory L Ahonen; Jose R Conejo-Garcia
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

5.  CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion.

Authors:  Yolanda Nesbeth; Uciane Scarlett; Juan Cubillos-Ruiz; Diana Martinez; Xavier Engle; Mary-Jo Turk; Jose R Conejo-Garcia
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

6.  Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

Authors:  Michael C Schmid; Judith A Varner
Journal:  J Oncol       Date:  2010-05-16       Impact factor: 4.375

7.  Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

Authors:  Juan R Cubillos-Ruiz; Xavier Engle; Uciane K Scarlett; Diana Martinez; Amorette Barber; Raul Elgueta; Li Wang; Yolanda Nesbeth; Yvon Durant; Andrew T Gewirtz; Charles L Sentman; Ross Kedl; Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

8.  Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.

Authors:  Jason R Baird; Barbara A Fox; Kiah L Sanders; Patrick H Lizotte; Juan R Cubillos-Ruiz; Uciane K Scarlett; Melanie R Rutkowski; Jose R Conejo-Garcia; Steven Fiering; David J Bzik
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

Review 9.  Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.

Authors:  Barbara A Fox; Kiah L Sanders; Shan Chen; David J Bzik
Journal:  Trends Parasitol       Date:  2013-08-05

10.  Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.

Authors:  Heather L Pulaski; Gregory Spahlinger; Ines A Silva; Karen McLean; Angela S Kueck; R Kevin Reynolds; George Coukos; Jose R Conejo-Garcia; Ronald J Buckanovich
Journal:  J Transl Med       Date:  2009-06-19       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.